A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.
about
Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infectionDiscordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.Characterization of novel Omp31 antigenic epitopes of Brucella melitensis by monoclonal antibodiesEvaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection.An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infectionCharacterization of periplasmic protein BP26 epitopes of Brucella melitensis reacting with murine monoclonal and sheep antibodies.Immunization with Brucella VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs.Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice.Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting.MicroRNA Expression Patterns of CD8+ T Cells in Acute and Chronic Brucellosis.Meta-Analysis and Advancement of Brucellosis Vaccinology.Nasal vaccination stimulates CD8(+) T cells for potent protection against mucosal Brucella melitensis challengeA history of the development of Brucella vaccines.Virulence factors in brucellosis: implications for aetiopathogenesis and treatment.Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.Coexpression of IL-18 strongly attenuates IL-12-induced systemic toxicity through a rapid induction of IL-10 without affecting its antitumor capacity.Confronting the barriers to develop novel vaccines against brucellosis.Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease.Construction of an expression plasmid (vector) encoding Brucella melitensis outer membrane protein, a candidate for DNA vaccine.In silico analysis of chimeric TF, Omp31 and BP26 fragments of Brucella melitensis for development of a multi subunit vaccine candidate.Development and trial of vaccines against Brucella.Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB/c mice.Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge.Immune reactivity of Brucella melitensis-vaccinated rabbit serum with recombinant Omp31 and DnaK proteins.Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria.Impact of heat shock protein 60KD in combination with outer membrane proteins on immune response against Brucella melitensis.Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection.
P2860
Q28658422-084B3CE5-72C0-438A-813D-F9934D46A39FQ33557772-4285F3E5-26FE-4673-92AF-C5C9E7ACD6A7Q33691610-DE8EB4C4-833D-4764-945C-123ECF8D3A4CQ33755285-15BAA7D8-4C58-4242-9155-5A8A7D14A3BEQ33802696-28DFAA27-15FF-49C5-9BFD-AED81090EC36Q34194709-F2E534DC-4DC3-4836-9505-B623433E290EQ34212243-A49F520E-93D9-441A-AF9F-26225811677FQ35122817-C88946B8-7551-4C0B-AB31-F35B6EEDAED2Q35191851-70F33B53-2960-4C7E-940B-B1481E1D5910Q35946874-83841FE1-AB76-420D-A2C1-642DAE47244EQ36185548-BEE4ED73-7A8B-45EB-A13C-C329716D7B2FQ36192841-11078202-546D-40D4-B145-5546269D3F7CQ36932453-685BFA89-D31B-4A0A-8022-119F556EA180Q36938722-75E6D352-CD3F-4D99-8D22-AF3E4F428687Q37035400-4957958D-22BB-4E2D-B5A5-2E5EAA56D7E1Q37078471-4D5D62B8-2E42-46FC-BBDB-67206E9D1D35Q37462813-C583EE6B-8994-4A19-AF15-EEF5EBB9B872Q37932521-F0B8F6F8-2DE7-4E8C-A02B-F32EA871CB7DQ37965725-1EA09115-75A8-4122-BFA0-E64FE02F41F3Q38533666-35FD1028-A13A-4441-905A-EE3885DC16D4Q39461733-C26F494E-D40B-4E42-9A8A-B86FF78ACAE7Q40072449-E614D1B0-E52F-4372-B256-559A3ADF64C2Q41691222-A533DD55-DE41-408C-A49F-1FD51D786BAFQ41761576-606C0FCB-C149-49B7-8FFC-145D8420887FQ41931666-0330C0D3-209A-4D93-89B6-B4825FF00ECBQ42909254-68CBEFFE-228B-4362-8CE5-E9298E11BD93Q46258488-4CA6DC7D-46D4-45EC-8036-CF3F0835B06DQ47163895-E8B8CECB-0ED7-423F-BBBC-38942B7887A9
P2860
A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
A DNA vaccine coding for the B ...... a specific cytotoxic response.
@ast
A DNA vaccine coding for the B ...... a specific cytotoxic response.
@en
A DNA vaccine coding for the B ...... a specific cytotoxic response.
@nl
type
label
A DNA vaccine coding for the B ...... a specific cytotoxic response.
@ast
A DNA vaccine coding for the B ...... a specific cytotoxic response.
@en
A DNA vaccine coding for the B ...... a specific cytotoxic response.
@nl
prefLabel
A DNA vaccine coding for the B ...... a specific cytotoxic response.
@ast
A DNA vaccine coding for the B ...... a specific cytotoxic response.
@en
A DNA vaccine coding for the B ...... a specific cytotoxic response.
@nl
P2093
P2860
P50
P1476
A DNA vaccine coding for the B ...... a specific cytotoxic response.
@en
P2093
Carlos A Velikovsky
Guillermo H Giambartolomei
Laura Bruno
Raúl Bowden
Silvia M Estein
Silvia de la Barrera
P2860
P304
P356
10.1128/IAI.73.10.6537-6546.2005
P407
P577
2005-10-01T00:00:00Z